Table 2. Patient appetite scores by cancer site, based on FAACT (N=1949) and VAS scores (N=1857).
| Cancer site | FAACT M0 |
FAACT M1 |
FAACT Total |
VAS appetite M0 | VAS appetite M1 | VAS appetite total |
|---|---|---|---|---|---|---|
| Breast | 33 ±5 | 29 ±5 | 32 ±5 | 73 ±20 | 69 ±19 | 73 ±20 |
| Genitourinary tract | 32 ±5 | 28 ±6 | 30 ±6 | 72 ±18 | 61 ±22 | 67 ±21 |
| Colorectal | 32 ±5 | 29 ±5 | 30 ±5 | 72 ±23 | 65 ±22 | 68 ±22 |
| Lung | 31 ±5 | 29 ±5 | 29 ±6 | 71 ±24 | 64 ±23 | 66 ±23 |
| Other cancer1 | 33 ±6 | 29 ±6 | 32 ±6 | 78 ±22 | 69 ±21 | 75 ±22 |
| Gastroesophageal | 27 ±6 | 23 ±6 | 25 ±6 | 58 ±23 | 52 ±21 | 54 ±21 |
| Pancreatic | 28 ±4 | 24 ±7 | 25 ±6 | 62 ±22 | 48 ±27 | 53 ±26 |
| Other GI | 34 ±5 | 28 ±6 | 30 ±5 | 69 ±18 | 62 ±21 | 63 ±21 |
| Liver/bile duct | 33 ±2 | 26 ±5 | 28 ±5 | 82 ±8 | 62 ±21 | 65 ±20 |
| Head and neck | 33 ±6 | 30 ±5 | 31 ±5 | 75 ±23 | 64 ±19 | 68 ±22 |
| Unknown primary site2 | 26 | 25±6 | 28 ±6 | 20 | 45 ±17 | 55 ±24 |
| ALL CANCERS | 32 ±5 | 28 ±6 | 30 ±6 | 72 ±21 | 62 ±23 | 67 ±23 |
Cutoff points for poor appetite are FAACT ≤30 and VAS appetite score VAS ≤70. M0 = stage I-III, M1 = stage IV. Data are expressed as Mean ±SD
1Other cancer includes: sarcoma, mesothelioma, mesenchymal, skin, endocrine and hematologic tumors.
2 N=1 if SD not indicated.
FAACT, Functional Assessment of Anorexia-Cachexia Therapy (questionnaire); VAS, visual analog scale of appetite SD, standard deviation.